We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+22.84%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.3%
AUM
$1.59B
AUM Growth
-$22.5M
(-1.4%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-11.29%
Top 10 Holdings %
Top 10 Hldgs %
7.3%
Holding
2,269
New
605
Increased
523
Reduced
559
Closed
577
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$5.95M |
| 2 |
TJX Companies
TJX
|
+$5.66M |
| 3 |
Medtronic
MDT
|
+$5.07M |
| 4 |
JHG
Janus Henderson
JHG
|
+$4.86M |
| 5 |
Essential Properties Realty Trust
EPRT
|
+$4.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$22.8M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$20M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$12.5M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$8.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.05% |
| 2 | Financials | 14.8% |
| 3 | Technology | 14.7% |
| 4 | Industrials | 13.56% |
| 5 | Consumer Discretionary | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPAI
1626
Safe Pro Group Inc
SPAI
$90.4M
| $97K | 0.01% |
22,378
-15,206
| -40% | -$69.2K |
|
1627
Aptevo Therapeutics
APVO
$3.31M
| $96K | 0.01% |
21,539
+1,901
| +10% | +$9.15K |
|
1628
Codexis
CDXS
$150M
| $94K | 0.01% |
41,811
-75,112
| -64% | -$187K |
|
1629
Annovis Bio
ANVS
$56.8M
| $93K | 0.01% |
49,904
+4,481
| +10% | +$8.71K |
|
1630
Grove Collaborative
GROV
$44.8M
| $93K | 0.01% |
74,502
+10,047
| +16% | +$12.4K |
|
|
NRT
1631
North European Oil Royalty Trust
NRT
$79.2M
| $91K | 0.01% |
12,415
-6,690
| -35% | -$54K |
|
1632
Owlet
OWLT
$148M
| $90K | 0.01% |
15,764
-18,844
| -54% | -$99.5K |
|
1633
Context Therapeutics
CNTX
$34.1M
| $89K | 0.01% |
+159,804
| New | +$324K |
|
|
SUNE
1634
SUNation Energy
SUNE
$16M
| $89K | 0.01% |
37,846
+12,653
| +50% | +$22.8K |
|
1635
Elutia
ELUT
$36.8M
| $88K | 0.01% |
+89,386
| New | +$94.9K |
|
1636
Hain Celestial
HAIN
$47.3M
| $88K | 0.01% |
+157,192
| New | +$117K |
|
1637
QuantumScape Corp
QS
$3.04B
| $85K | 0.01% |
11,207
-70,006
| -86% | -$525K |
|
1638
Ultrapar
UGP
$7.98B
| $84K | 0.01% |
+16,645
| New | +$91.6K |
|
|
YRD
1639
Yiren Digital
YRD
$86.1M
| $84K | 0.01% |
100,741
+9,391
| +10% | +$15.5K |
|
1640
Sabre
SABR
$908M
| $83K | 0.01% |
+39,555
| New | +$69.3K |
|
1641
Universal Electronics
UEIC
$67.6M
| $83K | 0.01% |
+17,370
| New | +$72.3K |
|
1642
Better Online Solutions
BOSC
$33.4M
| $80K | 0.01% |
17,746
+6,381
| +56% | +$28.7K |
|
1643
Solitario Resources
XPL
$59.7M
| $80K | 0.01% |
106,036
+36,878
| +53% | +$30.8K |
|
1644
Mativ Holdings
MATV
$672M
| $78K | ﹤0.01% |
+10,261
| New | +$88.4K |
|
1645
Vivani Medical
VANI
$111M
| $75K | ﹤0.01% |
+60,866
| New | +$73.6K |
|
1646
XBiotech
XBIT
$65.9M
| $71K | ﹤0.01% |
+30,654
| New | +$74.2K |
|
1647
Pangaea Logistics
PANL
$534M
| $70K | ﹤0.01% |
10,725
-23,540
| -69% | -$179K |
|
1648
Prelude Therapeutics
PRLD
$318M
| $68K | ﹤0.01% |
+12,672
| New | +$55.2K |
|
1649
Intellicheck
IDN
$48.6M
| $66K | ﹤0.01% |
16,135
-24,599
| -60% | -$147K |
|
1650
enGene Therapeutics
ENGN
$129M
| $65K | ﹤0.01% |
+37,346
| New | +$152K |
|
Similar funds
W
SW
PIS
ACM
CCP
FWP
NMC
LLL
GSA Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, GSA Capital Partners held 2,269 positions worth $1.59B, down 1.4% from $1.61B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
GSA Capital Partners withdrew a net $179M in Q2 2026, closing 577 positions and reducing 559 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $28M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
Against the trend, GSA Capital Partners opened a new position in Northrop Grumman worth $5.25M.
- GSA Capital Partners's largest Q2 2026 buy was Northrop Grumman: 10,314 shares worth $5.25M.
- GSA Capital Partners added most to TJX Companies in Q2 2026, an estimated $5.66M increase.
- GSA Capital Partners's biggest Q2 2026 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $20M.
- GSA Capital Partners fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $28M.
- GSA Capital Partners's ten largest holdings make up 7.3% of its $1.59B portfolio in Q2 2026.
- GSA Capital Partners opened 605 new positions and closed 577 in Q2 2026.
- GSA Capital Partners's portfolio value fell 1.4% quarter-over-quarter to $1.59B.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.